Vaccines for human medicine
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: > Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: > Vaccines for human medicine
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3002.41.00.00
Influenza Vaccine Quadrivalent (Fluzone)
A seasonal influenza vaccine protecting against four strains of flu virus, administered annually to humans. It is a human vaccine under HTS 3002.41.00.00 for prophylactic purposes.
Rotavirus Vaccine (Rotateq)
Oral pentavalent vaccine preventing rotavirus gastroenteritis in infants. HTS 3002.41.00.00 for human prophylactic vaccines.
Polio Vaccine Inactivated (IPOL)
Inactivated poliovirus vaccine for prevention of poliomyelitis. Human vaccine classified in HTS 3002.41.00.00.
Shingles Vaccine (Shingrix)
Recombinant zoster vaccine preventing herpes zoster (shingles) in adults. HTS 3002.41.00.00 as human vaccine.
Meningococcal Vaccine (Menactra)
Quadrivalent conjugate vaccine against meningococcal disease serogroups A,C,Y,W-135. Human vaccine under HTS 3002.41.00.00.
Pneumococcal Vaccine (Prevnar 13)
13-valent conjugate vaccine preventing pneumococcal disease in children and adults. HTS 3002.41.00.00 for humans.
Td Vaccine (Tenivac)
Tetanus and diphtheria toxoids for adult boosters. Prophylactic human vaccine in HTS 3002.41.00.00.
Japanese Encephalitis Vaccine (Ixiaro)
Inactivated vaccine for protection against Japanese encephalitis virus in travelers. Human medicine vaccine HTS 3002.41.00.00.
Pfizer-BioNTech COVID-19 Vaccine (Comirnaty)
This mRNA-based vaccine is used to immunize against SARS-CoV-2, the virus causing COVID-19. It falls under HTS 3002.41.00.00 as a vaccine for human medicine, specifically designed for prophylactic use against infectious disease.
Moderna COVID-19 Vaccine (Spikevax)
An mRNA vaccine targeting the spike protein of SARS-CoV-2 for prevention of COVID-19 in humans. Classified in HTS 3002.41.00.00 as a human vaccine product for prophylactic immunization.
HPV Vaccine (Gardasil 9)
Recombinant vaccine preventing human papillomavirus infections that cause cervical cancer and warts. HTS 3002.41.00.00 covers this as a biotechnological human vaccine.
Hepatitis B Vaccine (Engerix-B)
Recombinant vaccine providing immunity against Hepatitis B virus, used in pediatric and adult immunization programs. Fits HTS 3002.41.00.00 for human vaccines.
MMR Vaccine (Priorix)
Live attenuated vaccine against measles, mumps, and rubella for childhood immunization. Classified as a human vaccine under HTS 3002.41.00.00.
Varicella Vaccine (Varivax)
Live vaccine preventing chickenpox caused by varicella-zoster virus in humans. HTS 3002.41.00.00 applies to this prophylactic human vaccine.
DTaP Vaccine (Daptacel)
Combination vaccine against diphtheria, tetanus, and pertussis for pediatric use. As a human vaccine, it is under HTS 3002.41.00.00.